The U.S. Food and Drug Administration (FDA) may approve updated COVID-19 vaccines this week to combat recent strains as the country endures its most significant summer outbreak in two years.
The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc.
and Pfizer Inc. which is collaborating with BioNTech SE
The FDA is expected to give the nod to updated mRNA vaccines from Moderna, Inc.
and Pfizer Inc. which is collaborating with BioNTech SE
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch - Virtus LifeSci Biotech Products ETF (ARCA:BBP), BioNTech (NASDAQ:BNTX)
The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer outbreak.
www.benzinga.com